Optimization and development of Nisoldipine nano-bioenhancers by novel orthogonal array (L27 array)

International Journal of Biological Macromolecules

Volumn 86, Issue , 2016, Pages 556-561

  Rathee, Permender ^a   Kamboj, Anjoo ^b   Sidhu, Shabir ^a  

^a I K GUJRAL PUNJAB TECHNICAL UNIVERSITY   (India)

^b CHANDIGARH GROUP OF COLLEGES   (India)

Author keywords

Development; Nano bioenhancers; Nisolodipine; Optimization; PLGA; Statistical array

Indexed keywords

NANOPARTICLE; NISOLDIPINE; POLYGLACTIN; ANTIHYPERTENSIVE AGENT; DRUG CARRIER;

ARTICLE; CHEMICAL COMPOSITION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; ENTRAPMENT ENHANCEMENT; MATHEMATICAL MODEL; NANO BIOENHANCER; NANOTECHNOLOGY; ORTHOGONAL ARRAY; PARTICLE SIZE; PHASE SEPARATION; PHYSICAL PARAMETERS; PREDICTION; PROCESS OPTIMIZATION; SIGNAL NOISE RATIO; TRANSMISSION ELECTRON MICROSCOPY; BIOAVAILABILITY; CHEMISTRY; KINETICS; THEORETICAL MODEL;

ANTIHYPERTENSIVE AGENTS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG DESIGN; DRUG LIBERATION; KINETICS; MODELS, THEORETICAL; NISOLDIPINE; PARTICLE SIZE;

EID: 84956880503     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2016.01.097     Document Type: Article

References (20)

1. British Pharmacopoeia. Great Britain: The department of Health Social Services and Public Safety 2007.
2. Tatiraju V.D., Varsha B., Priya J., Karambelkar J., Jadhav M.V., Kadam V. J. Pharmacognosy Phytochem. 2013, 2:55-60.
3. Randhawa G., Kullar J.S. Int. J. Appl. Basic Med. Res. 2011, 1:5-10.
4. Drabu S., Khatri S., Babu S., Lohani P. Res. J. Pharm. Biol. Chem. Sci. 2011, 2:108-119.
5. Shaikh J., Ankola D., Beniwal V., Singh D., Kumar M.N. Eur. J. Pharm. Sci. 2009, 37:223-230.
6. Sangwan P., Koul J.L., Koul S., Reddy M., Thota N., Khan I.A. Bioorg. Med. Chem. 2008, 16:9847-9857.
7. G.N. Qazi, K.L. Bedi, R.K. Johri, M.K. Tikoo, A.K. Tikoo, S.C. Sharma, S.T. Abdullah, O.P. Suri, B.D. Gupta, K.A. Suri, R.K. Khajuria, United States Patent, Number (2006) 20060257505.
8. Richard E. J. Med. Plants Res. 2009, 3:1204-1211.
9. Kesarwani K., Gupta R. Asian Pacific J. Trop. Biomed. 2013, 235-266.
10. Nepolean R., Narayanan N., Subramaniyan N., Venkateswaran K., Vinoth J. Int. J. Biol. Pharm. Res. 2012, 3:962-967.
11. Rathee P., Dua K., Rathee S., Kumar V. Pharm. Anal. Acta 2014, 5:307.
12. Kumar V., Dua K., Rathee S., Rathee P. Pharm. Anal. Acta 2014, 5:319.
13. Drug.com, Nisoldipine package insert (Zeneca-US) Rev 12/96 1999 9/98.
14. Hiren K.M., Steven J.S. Polymers 2001, 3:1377-1397.
15. Allison S.D. J. Pharm. Sci. 2008, 97:2022-2035.
16. Ruhil S., Chaudhary H., Kumar V. Int. J. Biol. Macromol. 2014, 64:99-105.
17. Muhlen A.Z., Schwarz C. Eur. J. Pharm. Biopharm. 1998, 45:149-155.
18. Karthikeyan D., Srinivas M., Kumar S. Formulation and evaluation of stavudine nanoparticles. Int. J. Novel Trends Pharm. Sci. 2013, 3(1):24-32.
19. Mundargi R., Babu V., Rangaswamy V., Patel P., Aminabhavi T. J. Contr. Release 2008, 125:193-209.
20. ICH Guideline Q1A (R2), Stability Testing of New Drug Substances and Products 2003 1-18.